These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Change in the reactivity of the active-site serine OH of butyrylcholinesterase caused by a new reversible inhibitor. Gaál J; Bartha F; Batke J Eur J Biochem; 1983 Sep; 135(1):157-62. PubMed ID: 6884355 [TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509. Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor in rat heart and brain. Cohen-Armon M; Schreiber G; Sokolovsky M J Cardiovasc Pharmacol; 1984; 6(6):1148-55. PubMed ID: 6084773 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine. Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072 [TBL] [Abstract][Full Text] [Related]
7. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors. Van Den Beukel I; Dijcks FA; Vanderheyden P; Vauquelin G; Oortgiesen M J Pharmacol Exp Ther; 1997 Jun; 281(3):1113-9. PubMed ID: 9190843 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands. Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179 [TBL] [Abstract][Full Text] [Related]
9. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971. Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613 [TBL] [Abstract][Full Text] [Related]
10. The interaction between methylene blue and the cholinergic system. Pfaffendorf M; Bruning TA; Batnik HD; van Zwieten PA Br J Pharmacol; 1997 Sep; 122(1):95-8. PubMed ID: 9298533 [TBL] [Abstract][Full Text] [Related]
11. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR; Ferris DJ; Tilson HA; Mundy WR Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum. Nilvebrant L; Sparf B Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999 [TBL] [Abstract][Full Text] [Related]
13. Oxadiazolidinones: irreversible inhibition of cholinesterases and effects on acetylcholine receptors. Bakry NM; Sherby SM; Eldefrawi AT; Eldefrawi ME Neurotoxicology; 1986; 7(3):1-10. PubMed ID: 3822252 [TBL] [Abstract][Full Text] [Related]
14. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977 [TBL] [Abstract][Full Text] [Related]
15. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships. Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cholinergic properties of N-aryl-2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine. Valli MJ; Tang Y; Kosh JW; Chapman JM; Sowell JW J Med Chem; 1992 Aug; 35(17):3141-7. PubMed ID: 1507203 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats. Ma T; Kramer RE; Baker RC; Fan LW; Ho IK J Neurosci Res; 2003 Jan; 71(1):138-45. PubMed ID: 12478623 [TBL] [Abstract][Full Text] [Related]
18. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists. Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650 [TBL] [Abstract][Full Text] [Related]